Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume -, Issue -, Pages jnnp-2021-327788
Publisher
BMJ
Online
2022-01-26
DOI
10.1136/jnnp-2021-327788
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
- (2021) Henrik Zetterberg et al. Molecular Neurodegeneration
- Evaluation of Aducanumab for Alzheimer Disease
- (2021) G. Caleb Alexander et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neuroinflammation predicts disease progression in progressive supranuclear palsy
- (2021) Maura Malpetti et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
- (2021) Claudia Cicognola et al. Alzheimers Research & Therapy
- Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer’s disease
- (2021) Cécile Tissot et al. Alzheimers Research & Therapy
- Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
- (2021) Joana B Pereira et al. BRAIN
- Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
- (2021) Daniel Alcolea et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance
- (2021) Kasper Katisko et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Biomarkers for neurodegenerative diseases
- (2021) Oskar Hansson NATURE MEDICINE
- Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures
- (2021) Sebastian Palmqvist et al. NATURE MEDICINE
- Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
- (2021) Nicholas C. Cullen et al. Nature Communications
- A multicentre validation study of the diagnostic value of plasma neurofilament light
- (2021) Nicholas J. Ashton et al. Nature Communications
- Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease
- (2021) Zhenxu Xiao et al. Alzheimers Research & Therapy
- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
- (2020) Carolin Heller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
- (2020) Nicholas J. Ashton et al. Nature Reviews Neurology
- Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
- (2020) Juan Lantero Rodriguez et al. ACTA NEUROPATHOLOGICA
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- The revised Addenbrooke's Cognitive Examination can facilitate differentiation of dementia with Lewy bodies from Alzheimer's disease
- (2020) Maria Angeles Prats‐Sedano et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Plasma Phospho‐Tau Identifies Alzheimer's Co‐Pathology in Patients with Lewy Body Disease
- (2020) Sara Hall et al. MOVEMENT DISORDERS
- Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
- (2019) Patrick Oeckl et al. JOURNAL OF ALZHEIMERS DISEASE
- 123I-MIBG scintigraphy utility and cut-off value in a clinically representative dementia cohort
- (2019) J.P.M. Kane et al. PARKINSONISM & RELATED DISORDERS
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Plasma biomarkers of astrocytic and neuronal dysfunction in early‐ and late‐onset Alzheimer's disease
- (2019) Fanny M. Elahi et al. Alzheimers & Dementia
- Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies
- (2018) Paul C. Donaghy et al. MOVEMENT DISORDERS
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia
- (2018) Alan J. Thomas et al. Alzheimers Research & Therapy
- OUP accepted manuscript
- (2018) BRAIN
- Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers
- (2018) Andrea Vergallo et al. Alzheimers & Dementia
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- (2017) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses
- (2017) W Richard Bevan-Jones et al. BMJ Open
- Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
- (2015) Aiko Ishiki et al. JOURNAL OF NEUROCHEMISTRY
- Neuroinflammation in Lewy body dementia
- (2015) Ajenthan Surendranathan et al. PARKINSONISM & RELATED DISORDERS
- The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
- (2013) T. Rittman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Classification of primary progressive aphasia and its variants
- (2011) M. L. Gorno-Tempini et al. NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started